These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37747470)

  • 1. Combination effects of baicalin with linezolid against Staphylococcus aureus biofilm-related infections: in vivo animal model.
    Du Z; Han J; Luo J; Bi G; Liu T; Kong J; Chen Y
    New Microbiol; 2023 Sep; 46(3):258-263. PubMed ID: 37747470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial synergy between linezolid and baicalein against methicillin-resistant Staphylococcus aureus biofilm in vivo.
    Liu T; Luo J; Bi G; Du Z; Kong J; Chen Y
    Microb Pathog; 2020 Oct; 147():104411. PubMed ID: 32745664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
    Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
    Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
    Abad L; Tafani V; Tasse J; Josse J; Chidiac C; Lustig S; Ferry T; Diot A; Laurent F; Valour F
    J Antimicrob Chemother; 2019 Mar; 74(3):625-632. PubMed ID: 30517641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Linezolid and Fosfomycin in Catheter-Related Biofilm Infection Caused by Methicillin-Resistant Staphylococcus aureus.
    Chai D; Liu X; Wang R; Bai Y; Cai Y
    Biomed Res Int; 2016; 2016():6413982. PubMed ID: 27366751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of S. aureus biofilm formation by linezolid alleviates sepsis-induced lung injury caused by S. aureus infection through direct inhibition of icaA activity.
    Kuang H; Bi H; Li X; Lv X; Liu Y
    New Microbiol; 2023 Sep; 46(3):285-295. PubMed ID: 37747474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
    Hashem AA; Abd El Fadeal NM; Shehata AS
    J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents.
    Hogan S; O'Gara JP; O'Neill E
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo.
    Kaul G; Akhir A; Shukla M; Rawat KS; Sharma CP; Sangu KG; Rode HB; Goel A; Chopra S
    J Antimicrob Chemother; 2022 Aug; 77(9):2456-2460. PubMed ID: 35748613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Activity of Linezolid, Daptomycin and N-acetylcysteine Agents on Staphylococcus Aureus Biofilms in the Ventriculoperitoneal Shunt Model.
    Kuruoglu T; Onger ME; Turan DB; Kuruoglu E
    Turk Neurosurg; 2019; 29(1):66-71. PubMed ID: 29582407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections.
    Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M
    J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
    Tellis M; Joseph J; Khande H; Bhagwat S; Patel M
    J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Silvestri C; Orlando F; Kamysz W; Licci A; Nadolski P; Della Vittoria A; Łukasiak J; Scalise G; Saba V
    JPEN J Parenter Enteral Nutr; 2007; 31(6):463-8. PubMed ID: 17947600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of linezolid with fosfomycin against Staphylococcus aureus in vitro and in an experimental Galleria mellonella model.
    Li L; Chen H; Liu Y; Xu S; Wu M; Liu Z; Qi C; Zhang G; Li J; Huang X
    J Microbiol Immunol Infect; 2020 Oct; 53(5):731-738. PubMed ID: 30638785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
    Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
    Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial/anti-biofilm activity of expired blood platelets and their released products.
    Różalski MI; Micota B; Sadowska B; Paszkiewicz M; Więckowska-Szakiel M; Różalska B
    Postepy Hig Med Dosw (Online); 2013 Apr; 67():321-5. PubMed ID: 23619231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms.
    Guo P; Buttaro BA; Xue HY; Tran NT; Wong HL
    Eur J Pharm Biopharm; 2020 Jun; 151():189-198. PubMed ID: 32335285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.